上海莼試生物技術(shù)有限公司
主營(yíng)產(chǎn)品: ELISA試劑盒,ELISA試劑盒價(jià)格,ELISA試劑盒報(bào)價(jià) |
聯(lián)系電話
13585831301
公司信息
- 聯(lián)系人:
- 李小姐
- 電話:
- 021-59541103
- 手機(jī):
- 13585831301
- 售后電話:
- 13585831301
- 傳真:
- 021-60443211
- 地址:
- 上海市嘉定區(qū)嘉羅公路1661號(hào)
- 郵編:
參考價(jià) | 面議 |
- 型號(hào)
- 品牌
- 廠商性質(zhì) 經(jīng)銷商
- 所在地 上海市
更新時(shí)間:2017-07-23 21:52:18瀏覽次數(shù):386
聯(lián)系我們時(shí)請(qǐng)說明是環(huán)保在線上看到的信息,謝謝!
公司提供的松香酸514-10-3售后服務(wù)保證,貨源充足。嚴(yán)格的質(zhì)量控制體系,包括:優(yōu)級(jí)純,分析純,化學(xué)純,試劑級(jí),基準(zhǔn)試劑,實(shí)驗(yàn)純,教學(xué)試劑,高純?cè)噭?,色譜純,光譜純,電子純。
松香酸514-10-3售后服務(wù)其他中文名稱: 1,2,3,4,4a,4b,5,6,10,10a-十氫化-1,4a-二甲基-7-異丙基-1-菲甲酸;樅酸;松脂酸;熟松香;樹脂酸
英文名稱: Abietic acid
其他英文名稱: Rosin Acid;Sylvic Acid
產(chǎn)品規(guī)格: BR,75%
包 裝: 25克/100克
:514-10-3
C20H30O2=302.45
級(jí)別:BR
含量:≥75%(GC)
紅外光譜鑒別:和對(duì)照品匹配
熔點(diǎn):139~156℃
性狀:黃棕色或微黃色或黃紅色結(jié)晶或膏狀物或粉末。一種三環(huán)二萜類含氧化合物,是zui重要的樹脂酸之一。 不溶于水,溶于一般有機(jī)溶劑和稀氫氧化鈉溶液,溶于醇、苯、氯、丙酮、醚和二硫化碳。工業(yè)用的松香酸是黃色玻璃狀固體,熔點(diǎn)有時(shí)可低至85℃
用途:生化研究。天然產(chǎn)物合成的起始物質(zhì)
保存:2~8℃
產(chǎn)品名稱 | |
英文名稱 | Abietic acid |
發(fā)貨 | 上海 |
特點(diǎn):
1.現(xiàn)貨直銷,當(dāng)天下單,當(dāng)天發(fā)貨。
2.產(chǎn)品優(yōu)質(zhì),到貨快,免費(fèi)快遞。
3.售前、售中、售后服務(wù)好。
有全、新、優(yōu)、品、好五大特點(diǎn):
全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
品:公司代理sigma,amresco,oxoid,wako,R&D,RB,MBL,TCI,GIBIO,等國(guó)內(nèi)外。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
我們提供試劑品牌有Merck、Spectrum、BioAssay Systems、Jaica、Scharlab、Sigma-Aldrich、Amresco、Amersham等試劑品牌,試劑純度高、規(guī)格多、包裝好,規(guī)格包括:優(yōu)級(jí)純,分析純,化學(xué)純,試劑級(jí),基準(zhǔn)試劑,實(shí)驗(yàn)純,教學(xué)試劑,高純?cè)噭V純,光譜純,電子純。
鹽酸 302543-62-0 HPLC≥98%;20mg 訂購|咨詢
112529-15-4 HPLC≥98%;20mg 訂購|咨詢
異香蘭素 621-59-0 HPLC≥98%;20mg 訂購|咨詢
異龍腦 124-76-5 HPLC≥98%;20mg 訂購|咨詢
鹽酸拓?fù)涮婵?nbsp; 119413-54-6 HPLC≥98%;20mg 訂購|咨詢
異去甲蟛蜞菊內(nèi)酯 6468-55-9 HPLC≥98%;5mg 訂購|咨詢
亞麻酸乙酯 1191-41-9 HPLC≥98%;20mg 訂購|咨詢
新西蘭牡荊苷 23666-13-9 HPLC≥98%;10mg 訂購|咨詢
纈草醚醛 67910-07-0 HPLC≥98%;10mg 訂購|咨詢
關(guān)附甲素 1394-48-5 HPLC≥98%;10mg 訂購|咨詢
旋復(fù)花內(nèi)酯 33627-41-7 HPLC≥98%;10mg 訂購|咨詢
8-香葉草氧基補(bǔ)骨脂素 7437-55-0 HPLC≥98%;20mg 訂購|咨詢
熊果酸乙酸酯 7372-30-7 HPLC≥98%;20mg 訂購|咨詢
細(xì)辛醛 4460-86-0 HPLC≥98%;20mg 訂購|咨詢
香葉醇 106-24-1 HPLC≥98%;20mg 訂購|咨詢
小檗紅堿硫酸酯 HPLC≥98%;20mg 訂購|咨詢
腺嘌呤 73-24-5 HPLC≥98%;20mg 訂購|咨詢
9-硝基 86639-62-5 HPLC≥98%;20mg 訂購|咨詢
香草醇 498-00-0 HPLC≥98%;20mg 訂購|咨詢
雪 77-53-2 HPLC≥98%;20mg 訂購|咨詢
血竭素 400603-95-4 HPLC≥98%;20mg 訂購|咨詢
西貝母堿苷 HPLC≥98%;10mg 訂購|咨詢
繡球酚 480-47-7 HPLC≥98%;20mg 訂購|咨詢
新對(duì)葉百部堿 143120-46-1 HPLC≥98%;20mg 訂購|咨詢
小蕓木素 15085-71-9 HPLC≥98%;10mg 訂購|咨詢
薟精醇 5940-00-1 HPLC≥98%;20mg 訂購|咨詢
-7-甲醚 19492-03-6 HPLC≥98%;20mg 訂購|咨詢
人參皂苷Rk3 364779-15-7 HPLC≥98%;20mg 訂購|咨詢
人參炔醇 21852-80-2 HPLC≥98%;20mg 訂購|咨詢
肉豆寇酸單甘油酯 589-68-4 HPLC≥98%;20mg 訂購|咨詢
肉豆蔻酸甘油三酯 555-45-3 HPLC≥98%;20mg 訂購|咨詢
肉豆蔻醚 607-91-0 HPLC≥98%;20mg 訂購|咨詢
忍冬苷 HPLC≥98%;10mg 訂購|咨詢
日蟾蜍他靈 465-11-2 HPLC≥98%;10mg 訂購|咨詢
瑞枯靈 485-19-8 HPLC≥98%;20mg 訂購|咨詢
肉豆蔻酸 544-63-8 HPLC≥98%;20mg 訂購|咨詢
(S型)人參皂苷Rh2 67400-17-3 HPLC≥98%;20mg 訂購|咨詢
,5-DMMA (10 mg) 2,5-dimethoxy-N,α-dimethyl-benzeneethanamine; 2,5-Dimethoxymethamphetamine; 2,5-DMMA
2,5-DMMA (5 mg) 2,5-dimethoxy-N,α-dimethyl-benzeneethanamine; 2,5-Dimethoxymethamphetamine; 2,5-DMMA
2,5-DMMA (50 mg) 2,5-dimethoxy-N,α-dimethyl-benzeneethanamine; 2,5-Dimethoxymethamphetamine; 2,5-DMMA
Anatabine (tartrate) (10 mg) 1,2,3,6-tetrahydro-2,3’-bipyridine 2,3-dihydroxysuccinate; Anatabine (tartrate)
Anatabine (tartrate) (100 mg) 1,2,3,6-tetrahydro-2,3’-bipyridine 2,3-dihydroxysuccinate; Anatabine (tartrate)
Anatabine (tartrate) (5 mg) 1,2,3,6-tetrahydro-2,3’-bipyridine 2,3-dihydroxysuccinate; Anatabine (tartrate)
Anatabine (tartrate) (50 mg) 1,2,3,6-tetrahydro-2,3’-bipyridine 2,3-dihydroxysuccinate; Anatabine (tartrate)
Lck Inhibitor (1 mg) 7-cyclopentyl-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine; RK 24466|Lymphocyte-specific protein tyrosine kinase; Lck Inhibitor
Lck Inhibitor (5 mg) 7-cyclopentyl-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine; RK 24466|Lymphocyte-specific protein tyrosine kinase; Lck Inhibitor
Z-Asp-CH2-DCB (10 mg) (3S)-4-carboxy-2-oxo-3-[[(phenylmethoxy)carbonyl]amino]butyl ester 2,6-dichloro-benzoic acid; Z-Asp-2,6-Dichlorobenzoyloxymethyl Ketone; Z-Asp-CH2-DCB
Z-Asp-CH2-DCB (25 mg) (3S)-4-carboxy-2-oxo-3-[[(phenylmethoxy)carbonyl]amino]butyl ester 2,6-dichloro-benzoic acid; Z-Asp-2,6-Dichlorobenzoyloxymethyl Ketone; Z-Asp-CH2-DCB
Z-Asp-CH2-DCB (5 mg) (3S)-4-carboxy-2-oxo-3-[[(phenylmethoxy)carbonyl]amino]butyl ester 2,6-dichloro-benzoic acid; Z-Asp-2,6-Dichlorobenzoyloxymethyl Ketone; Z-Asp-CH2-DCB
Z-Asp-CH2-DCB (50 mg) (3S)-4-carboxy-2-oxo-3-[[(phenylmethoxy)carbonyl]amino]butyl ester 2,6-dichloro-benzoic acid; Z-Asp-2,6-Dichlorobenzoyloxymethyl Ketone; Z-Asp-CH2-DCB
Nelfinavir (mesylate) (10 mg) (3S,4aS,8aS)-N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide, monomethanesulfonate; AG-1343|Nelfin|Viracept; Nelfinavir (mesylate)
Nelfinavir (mesylate) (25 mg) (3S,4aS,8aS)-N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide, monomethanesulfonate; AG-1343|Nelfin|Viracept; Nelfinavir (mesylate)
Nelfinavir (mesylate) (5 mg) (3S,4aS,8aS)-N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide, monomethanesulfonate; AG-1343|Nelfin|Viracept; Nelfinavir (mesylate)
Nelfinavir (mesylate) (50 mg) (3S,4aS,8aS)-N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide, monomethanesulfonate; AG-1343|Nelfin|Viracept; Nelfinavir (mesylate)
Antalarmin (hydrochloride) (10 mg) N-butyl-N-ethyl-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, monohydrochloride; Antalarmin (hydrochloride)
Antalarmin (hydrochloride) (25 mg) N-butyl-N-ethyl-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, monohydrochloride; Antalarmin (hydrochloride)
Antalarmin (hydrochloride) (5 mg) N-butyl-N-ethyl-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, monohydrochloride; Antalarmin (hydrochloride)
Antalarmin (hydrochloride) (50 mg) N-butyl-N-ethyl-2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, monohydrochloride; Antalarmin (hydrochloride)
Abiraterone Acetate (10 mg) (3β)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol, acetate ester; CB-7630|Zytiga ; Abiraterone Acetate
Abiraterone Acetate (25 mg) (3β)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol, acetate ester; CB-7630|Zytiga ; Abiraterone Acetate
Abiraterone Acetate (5 mg) (3β)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol, acetate ester; CB-7630|Zytiga ; Abiraterone Acetate
Abiraterone Acetate (50 mg) (3β)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol, acetate ester; CB-7630|Zytiga ; Abiraterone Acetate
Ro 3306 (1 mg) 5Z-(6-quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone; Ro 3306
Ro 3306 (5 mg) 5Z-(6-quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone; Ro 3306
Indinavir (sulfate) (10 mg) 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-D-erythro-pentonamide, monosulfate; Crixivan|L-735,524|MK 639; Indinavir (sulfate)
Indinavir (sulfate) (25 mg) 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-D-erythro-pentonamide, monosulfate; Crixivan|L-735,524|MK 639; Indinavir (sulfate)
Indinavir (sulfate) (5 mg) 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-D-erythro-pentonamide, monosulfate; Crixivan|L-735,524|MK 639; Indinavir (sulfate)
Indinavir (sulfate) (50 mg) 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-D-erythro-pentonamide, monosulfate; Crixivan|L-735,524|MK 639; Indinavir (sulfate)
Cdk2 Inhibitor II (1 mg) 4-[2-(5-bromo-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazinyl]-benzenesulfonamide; Cyclin-Dependent Kinase 2 Inhibitor II|SC-221409; Cdk2 Inhibitor II
Cdk2 Inhibitor II (5 mg) 4-[2-(5-bromo-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazinyl]-benzenesulfonamide; Cyclin-Dependent Kinase 2 Inhibitor II|SC-221409; Cdk2 Inhibitor II
Cdk2 Inhibitor II (500 ug) 4-[2-(5-bromo-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazinyl]-benzenesulfonamide; Cyclin-Dependent Kinase 2 Inhibitor II|SC-221409; Cdk2 Inhibitor II
Flubromazepam (1 mg) 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; Flubromazepam
Flubromazepam (10 mg) 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; Flubromazepam
Flubromazepam (5 mg) 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; Flubromazepam
HQNO (10 mg) 2-heptyl-4-quinolinol 1-oxide; KF8940|N-oxo-2-heptyl-4-Hydroxyquinoline|Pyo II; HQNO
HQNO (5 mg) 2-heptyl-4-quinolinol 1-oxide; KF8940|N-oxo-2-heptyl-4-Hydroxyquinoline|Pyo II; HQNO
HQNO (50 mg) 2-heptyl-4-quinolinol 1-oxide; KF8940|N-oxo-2-heptyl-4-Hydroxyquinoline|Pyo II; HQNO
PPACK (1 mg) D-phenylalanyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-chloroacetyl)butyl]-L-prolinamide; D-Phenylalanyl-prolyl-arginyl Chloromethyl Ketone|Pebac; PPACK
PPACK (10 mg) D-phenylalanyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-chloroacetyl)butyl]-L-prolinamide; D-Phenylalanyl-prolyl-arginyl Chloromethyl Ketone|Pebac; PPACK
PPACK (25 mg) D-phenylalanyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-chloroacetyl)butyl]-L-prolinamide; D-Phenylalanyl-prolyl-arginyl Chloromethyl Ketone|Pebac; PPACK
PPACK (5 mg) D-phenylalanyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-chloroacetyl)butyl]-L-prolinamide; D-Phenylalanyl-prolyl-arginyl Chloromethyl Ketone|Pebac; PPACK